Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sumagen
ClinicalTrials.gov Identifier:
NCT01546818
First received: June 9, 2009
Last updated: September 5, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)